|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Bad debt expense | |||||
| Depreciation and amortization | |||||
| Amortization of share-based compensation | |||||
| Amortization of debt issuance costs | |||||
| Provision for (or reversal of) credit losses on available-for-sale debt securities | |||||
| Book overdraft increase (decrease) | |||||
| Net realized (gains) losses on sale of investments | |||||
| Net change in unrealized (gains) losses on investments | |||||
| Amortization of premium/accretion of discount, net | |||||
| Deferred income taxes | |||||
| Excess tax (benefit) shortfall from share-based compensation | |||||
| Loss (gain) on disposal of assets | |||||
| Net change in assets and liabilities relating to operating activities: | |||||
| Prepaid reinsurance premiums | |||||
| Reinsurance recoverable | |||||
| Income taxes payable | |||||
| Premiums receivable, net | |||||
| Accrued investment income | |||||
| Income taxes recoverable | |||||
| Deferred policy acquisition costs | |||||
| Other assets | |||||
| Unpaid losses and loss adjustment expenses | |||||
| Unearned premiums | |||||
| Commission payable | |||||
| Reinsurance payable, net | |||||
| Other liabilities and accrued expenses | |||||
| Advance premium | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from sale of property and equipment | |||||
| Purchases of property and equipment | |||||
| Purchases of equity securities | |||||
| Purchases of available-for-sale debt securities | |||||
| Purchases of other investments | |||||
| Purchases of investment real estate, net | |||||
| Proceeds from sales of equity securities | |||||
| Proceeds from sales of available-for-sale debt securities | |||||
| Proceeds from sales of investment real estate | |||||
| Proceeds from sale of assets held for sale | |||||
| Proceeds from sale of other investments | |||||
| Maturities of available-for-sale debt securities | |||||
| Net cash provided by (used in) investing activities | |||||
| Proceeds from issuance of long-term debt | |||||
| Cash flows from financing activities: | |||||
| Debt issuance costs paid | |||||
| Preferred stock dividend | |||||
| Common stock dividend | |||||
| Purchase of treasury stock, inclusive of excise taxes paid | |||||
| Payments related to tax withholding for share-based compensation | |||||
| Repayment of debt | |||||
| Net cash provided by (used in) financing activities | |||||
| Cash and cash equivalents, and restricted cash and cash equivalents: | |||||
| Net increase (decrease) during the period | |||||
| Balance, beginning of period | |||||
| Balance, end of period | |||||
| Supplemental cash and non-cash flow disclosures: | |||||
| Interest paid | |||||
| Income taxes paid | |||||
| Income tax refund | |||||
| Cash and cash equivalents | |||||
| Restricted cash and cash equivalents | |||||
Loading...